Evolus, Inc. logo

Evolus, Inc.

NASDAQ:EOLS

Overview | Financials
Company Name Evolus, Inc.
Symbol EOLS
Currency USD
Price 11.77
Market Cap 736,925,585
Dividend Yield 0%
52-week-range 7.11 - 15.433
Industry Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. David Moatazedi
Website https://www.evolus.com

An error occurred while fetching data.

About Evolus, Inc.

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was

Related Stocks

Rocket Pharmaceuticals, Inc. logo

Rocket Pharmaceuticals, Inc.

RCKT

22.5 USD

The Oncology Institute, Inc. logo

The Oncology Institute, Inc.

TOI

0.47 USD

Codexis, Inc. logo

Codexis, Inc.

CDXS

3.2 USD

Nektar Therapeutics logo

Nektar Therapeutics

NKTR

1.42 USD

SIGA Technologies, Inc. logo

SIGA Technologies, Inc.

SIGA

8.72 USD

Merus N.V. logo

Merus N.V.

MRUS

57.26 USD

uniQure N.V. logo

uniQure N.V.

QURE

8.72 USD

Financials

Numbers are in millions USD

Numbers are in millions USD